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Abstract
Background: Implant infections are a major complication in the field of orthopaedics. Bacteria attach to the
implant-surface and form biofilm-colonies which makes them difficult to treat. Not only immune cells exclusively
respond to bacterial challenges, but also local tissue cells are capable of participating in defense mechanisms. The aim
of this study was to evaluate the role of osteoblasts in the context of implant infections.
Methods: Primary osteoblasts were cultivated and stimulated with free-swimming bacteria at 4 °C and 37 °C.
Supernatants were harvested for ELISA and expression of pro-inflammatory cytokines evaluated by RT-PCR.
Bacterial binding to osteoblasts was evaluated using cytofluorometry and uptake was investigated by 3H
thymidine-labelling of bacteria. Osteoblasts were additionally stimulated with the extracellular polymeric substance
(EPS) of Staphylococcus epidermidis biofilms, as well as components of the EPS; the bacterial heat shock protein GroEL
in particular.
Results: We demonstrated that binding of bacteria to the osteoblast cell surface leads to an increased production of
pro-inflammatory cytokines. Bacteria are capable of surviving intracellular. Furthermore, osteoblasts do not only
respond to free-swimming, planktonic bacteria, but also to components of the EPS, including lipoteichoic acid
and the heat shock protein GroEL.
Conclusion: In conclusion, local tissue cells, specifically osteoblasts, might contribute to the persistence of the
inflammatory response associated with implant-infections.
Keywords: Osteoblast, Biofilm infection, GroEL, Extracellular polymeric substance
Background
Osteoblasts are primarily studied in the context of bone
turnover and fracture healing. However, they can also
acquire characteristics of inflammatory cells. For ex-
ample, in response to bacterial challenge synthesis and
release of pro-inflammatory cytokines is described, in-
cluding generation of CXCL8 (interleukin 8, IL-8) or
CCL2 (monocyte chemoattractant protein-1, MCP-1).
Because both, CXCL8 and CCL2, attract leukocytes,
the local inflammatory response might escalade [1–4]
(for review see [5, 6]). Of note, osteoblasts also ac-
quire properties of antigen presenting cells. Following
uptake of Staphylococcus aureus, expression of MHC
class II molecules and of co-stimulatory receptors was
described [7, 8], as was the ability of MHC class II
positive osteoblasts to present superantigens to T
lymphocytes. Furthermore, osteoblasts produce defensin,
a molecule with bactericidal activity that was initially de-
scribed in leukocytes [9].
Osteoblasts take up bacteria by an active process
[10, 11]. Whether this uptake is a host defence reac-
tion, analogous to the bacteriophagocytosis by leuko-
cytes is still an open question. Under experimental
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conditions, ingested bacteria survive within the cell, lead-
ing to the notion that the osteoblast might provide a safe
hiding place, which - in consequence - might contribute
to the persistence of an infection [12–16].
Interactions of bacteria, either with phagocytic cells or
osteoblasts, are mainly studied with free-swimming,
planktonic bacteria. However, this is not the only life-
style of bacteria, and possibly not even the preferred
one, which was recognised over the last few years.
Rather, many bacteria species live in structured colonies,
embedded in an extracellular polymeric substance, so-
called “biofilms” [17–20]. By means of biofilm formation,
opportunistic bacteria in particular may acquire a patho-
genic potential.
Our research group is particularly interested in infec-
tions due to biofilm formation on orthopaedic implants.
In these infections, staphylococci species are prevalent
[21]. Extensive inflammation around the implant occurs,
which eventually results in bone degradation and in
loosening of the prosthesis. Analysis of the local host re-
sponse revealed infiltration of phagocytic cells, particu-
larly of neutrophils, generation of pro-inflammatory
cytokines and increased development of bone-resorbing
osteoclasts [22–24].
A likely source for these cytokines are infiltrating
neutrophils, which are activated by bacterial biofilms.
Of note, entities within the extracellular substance of
the biofilm activate neutrophils, among those peptido-
glycan, lipoteichoic acid and the bacterial heat shock
protein GroEL [25, 26]. Another source could be osteo-
blasts, which are also known to produce cytokines after
appropriate stimulation [3–5]. We now addressed the
question whether osteoblasts are not only activated by
planktonic staphylococci, but by entities derived from
bacterial biofilms.
Methods
Culture of osteoblasts
Primary osteoblasts were cultivated from human bone
marrow which was harvested either from the femoral
bone using the RIA (reamer-irrigator-aspirator)-tech-
nique or from the iliac crest of patients undergoing sur-
gery due to fracture malunion or non-union, and who
required an autologous bone graft. Informed consent
was obtained from the patients, and the study was
approved by the local ethic committee of Heidelberg
University (S-355/2010; October 28th 2010). Samples
were grinded using sterile scalpels and cultivated in
osteoblast growth medium (PromoCell, Heidelberg,
Germany) containing 0.1 % penicillin/streptomycin
(Gibco Life Technologies, Eggenstein, Germany). Out-
growth of cells occurred usually between 4 to 8 days.
Cells were subcultivated following digestion with trypsin
(0.05 % Trypsin-EDTA, Life Technologies) for 5 min at
37 °C and resuspended in osteoblast growth medium.
After 10 to 14 days, homogenous cell layers were
seen; osteoblasts were identified by expression of col-
lagen type I and bone sialoglycoprotein, and lack of
markers for myeloid cells (CD11b, CD68) (all from
Beckman Coulter, Krefeld, Germany) as seen by laser
scan microscopy and by cytofluorometry of detached
cells. Expression of CD90 (Beckman Coulter, Krefeld,
Germany) was used as a marker for de-differentiation.
Osteoblasts were used for a maximum of two passages
and experiments were carried out in 6 or 24-well dishes
(NuncTM, Wiesbaden, Germany) at a concentration of
2 × 105 cells/mL in osteoblast growth medium.
Cytofluorometry and microscopy
Cytofluorometry was performed with paraformaldehyde-
fixed osteoblasts using FACS Calibur and Cell quest pro
as software (Becton and Dickinson, Heidelberg, Germany).
Presence of collagen type I and bone sialoglycoprotein
was assessed by indirect immunofluorescence. Slides were
viewed by Laser scan microscopy (LSM, Leica).
Stimulation of osteoblasts by bacteria
Staphylococcus aureus (Seattle 1945, ATCC 25923,
Wesel, Germany) and Staphylococcus epidermidis
(RP62a, ATCC 35984) were grown overnight on a blood
agar plate at 37 °C (number PB5039A, Thermo Scien-
tific, Germany, Wesel). The following day, bacteria were
scraped of the plate, suspended in phosphate buffered
saline and adjusted to 1x108 cells/mL. Bacteria were
added in a ratio of 1:20, 1:100 and 1:500 bacteria per
osteoblast (2x105 cells per well in a 6-well culture dish
in a volume of 4 mL) and incubated at either 4 °C or
37 °C for the times indicated in the respective experi-
ments (two different temperatures were compared, be-
cause phagocytosis is impaired at 4 °C). The supernatant
was discarded and 1600 μg vancomycin/4 mL osteoblast
growth medium was added for 30 min. The supernatant
was discarded and replaced with 4 mL osteoblast growth
medium containing 80 μg vancomycin and culture was
continued for the times indicated in the respective ex-
periment. In another set of experiments, heparin 200 μg
(Heparin Sodium 25000, Ratiopharm, Ulm, Germany)
was added before stimulation with bacteria and pre-
incubated at room temperature for 10 min. After that,
bacteria were added and experiments carried out as de-
scribed above.
For RT-PCR analysis, cells were collected in 400 μL
lysis buffer from the MagnaPure mRNA Isolation Kit
I containing 1 % DTT (v/w) (ROCHE Applied Sciences -
RAS, Mannheim, Germany). To determine release of cyto-
kines, culture was continued for 6 h, 24 h and 48 h
at 37 °C. Supernatants were then harvested and
stored at−20 °C for ELISA (see below).
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Binding of bacteria to osteoblasts
FITC-labelled dead S. aureus were purchased (Molecu-
lar probes, S-2851, ThermoFisher Scientific, Schwerte,
Germany). S. epidermidis were labelled with fluorescein
isothiocyanate (FITC) according to the following proto-
col: FITC isomer I was purchased (Sigma- Aldrich,
Darmstadt, Germany; F7250). A 5 mg/mL DMSO stock
solution was diluted in phosphate buffered saline 1:10
(end concentration 0.5 mg/mL) and was incubated with
bacteria (8x107) for 45 min at 37 °C. Following repeated
washing, the bacteria were suspended in 4 % formalde-
hyde. FITC-labelling of bacteria was evaluated by cyto-
fluorometry. Binding of FITC-labeled bacteria to
osteoblasts was determined by incubating with bacteria
at a ratio of 1:100 bacteria per osteoblast for 2 h at ei-
ther 37 °C or 4 °C, followed by cytofluorometry and by
laser scan microscopy.
To visualise uptake of bacteria, osteoblasts were incu-
bated with FITC-labelled bacteria (see below) at a ratio of
1:100 for 2 h. The cells were fixed and viewed by LSM.
Uptake of 3H thymidine-labelled bacteria
An overnight culture of S. epidermidis in trypticase soy
broth was performed. The next morning 2 mL of the
overnight culture were added to 20 mL fresh trypticase
soy broth containing 100 μL 3H Thymidin (Amersham,
UK, TRA120 1 mCi/mL) and culture was continued for
4 h. Radioactivity associated with the bacteria was quan-
tified. Osteoblasts were then incubated with the labelled
bacteria as described above for 3 h. Then cell-associated
radioactivity was measured in an aliquot, the remaining
cells were treated with vancomycin to kill adherent, but
not internalised cells (as described above), then lysed.
An aliquot of the lysate was placed onto agar plates, and
colonies were counted after 24 h.
Formation of biofilms and extraction of the extracellular
polymeric substance (EPS)
S. epidermidis was added to 1.5 L of pre-warmed Trypti-
case Soy Broth (TSB) to reach a final concentration of
3x106 CFU/mL, then transferred to 30 polysterol dishes
(Nunc 150x20, Thermo Fisher Scientific, Roskilde,
Denmark) with a final volume of 50 mL per dish. After
incubation for 2 days at 37 °C without shaking, the
medium was removed and the remaining biofilm was
scrapped off. The following treatment was adapted from
Liu et al. (2002) [27]: per 10 mL of slime, 60 μL of 37 %
formaldehyde was added and mixed for 1 h at 4 °C,
followed by the addition of 4 mL 1 M NaCl and mixing
for another 3 h at 4 °C. The resulting suspension was
then centrifuged (Sorvall 5B Plus) for 15 min
(18000 rpm at 4 °C). The pellet was discarded, the super-
natant filtrated (Millex Syringe-driven Filter Unit
0.22um, Merck Milipore Ltd, Tullagreen, Ireland) and
then dialysed overnight against Milipore water at 4 °C
(membrane cut off 3600 Da; Spectrum Labs, Rancho
Dominguez, CA, USA). The water was replaced and
the isolated EPS was again dialysed for another 3 h,
then concentrated using Vivaspin 20 (Sartorius Stedim
Biotech, Göttingen, Germany) to a final volume of 4 mL
and frozen at−20 °C until use. Extraction of EPS from 1.79
square meters biofilm yielded on average 44.9 mg of
protein.
To detect possible endotoxin contamination a lim-
ulus assay was performed (Pierce LAL Chromogenic
Endotoxin Quantitation Kit, Thermo Scientific, Bonn,
Germany) following the instructions provided by the
manufacturer. The adsorption of LPS was accomplished
using Pierce High Capacity Endotoxin Removal Spin Col-
umn following the instructions provided but adjusting the
incubation time to 2 h in order to maximize LPS-removal.
Stimulation of osteoblasts
LTA (Sigma Aldrich) and recombinant GroEL (Enzo Life
Sciences) were purchased. Osteoblasts were cultivated
with LTA1 or LTA5 (1 μg/mL and 5 μg/mL, respect-
ively), GroEL1 and GroEL5 (1 μg/mL and 5 μg/mL, re-
spectively) or EPS2 and EPS10 (2 % and 10 % (v/v)).
Supernatants were collected after 6 h and 24 h incuba-
tion time at 37 °C and cells were collected in lysis buffer
for RT-PCR-analysis (see below).
Quantitative real-time polymerase chain reaction
Cells were collected in 400 μL lysis buffer from the
MagnaPure mRNA Isolation Kit I containing 1 %
DTT (v/w) (ROCHE Applied Sciences - RAS, Mann-
heim). mRNA was isolated with the MagnaPure-LC
device using the mRNA-I standard protocol. An ali-
quot was reversely transcribed using AMV-RT and
oligo-(dT) as primer (First Strand cDNA synthesis kit,
Roche) according to the manufactures protocol in a
thermocycler. Primer sets optimized for the LightCycler®
(RAS, Mannheim Germany) were developed and pur-
chased from SEARCH-LC GmbH (www.Search-LC.com).
The PCR was performed with the LightCycler® FastStart
DNA Sybr GreenI kit (RAS) according to the protocol
provided in the parameter specific kits. To control for spe-
cificity of the amplification products, a melting curve ana-
lysis was performed. The copy number was calculated
from a standard curve, obtained by plotting known input
concentrations of four different plasmids at log dilutions
to the PCR-cycle number (CP) at which the detected
fluorescence intensity reaches a fixed value. To correct for
differences in the content of mRNA, the calculated tran-
script numbers were normalized according to the expres-
sion of the housekeeping gene peptidylprolyl isomerase B
(PPIB). Values were thus given as transcripts per 1000
transcripts of PPIB.
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ELISA
IL-8, IL-6 and CCL2 in cell culture supernatants were
determined using commercially available ELISA kits ac-
cording to the protocol provided by the manufacturer.
The human Elisa kits were purchased from R& D
Systems (Minneapolis, USA).
Statistical analysis
Differences between groups were calculated using
ANOVA one-way or Mann–Whitney test using Origin 9.0
software. Significance level was determined as P < 0.05.
Results
Osteoblasts in culture
Numerous methods are available to raise osteoblasts
from bone marrow. Under our culture conditions and
with use of a special medium that prevented growth of
fibroblasts, homogenous cultures were obtained within
10–14 days. Characteristic for osteoblasts is the
production of type I collagen and of bone sialoglyco-
protein (examples in Fig. 1a–e) and lack of markers
for myeloid cells (CD11b, CD68) (data not shown).
Under culture conditions, osteoblasts undergo a dedif-
ferentiation, which can be followed up by the acquisi-
tion of the surface protein CD90, the expression of
which increased steadily with time in culture, or
number of passage, respectively (Fig. 1f ). For our ex-
periments we used cells in passage 1 and 2, only.
Cells derived from different donors varied somewhat
with regard to their response to bacterial challenges,
which explains the wide variation seen in some of the
experiments.
Phagocytosis of bacteria and release of cytokines
To assess binding and uptake of bacteria, osteoblasts
were cultivated with FITC-labelled S. epidermidis or S.
aureus, respectively. At 4 °C, binding and association of
bacteria with osteoblasts was seen by cytofluorometry
CD90
MFI:        740                1883                   1914               2335
P1                      P2                       P3                      P4      
A                    B                        C
D                           E
F
BSP
Fig. 1 Culture and characterization of osteoblasts: Bone marrow was shredded and cultivated. a Osteoblasts started growing and after 10–14
days (the asterix indicates bone); b a near confluent layer of homogenous cells was obtained. c The cells produced collagen type I (stained in red;
nuclei in blue); and d bone sialoglycoprotein (BSP) (stained in green) as seen by laser scan microscopy and e by cytofluorometry of detached cells
(thick line; the thin line shows the isotype control). f The osteoblasts in early passage express CD90 (thick line; the thin line shows the isotype control);
expression increases with time in culture and passage number as seen by an increase of the mean fluorescence intensity (MFI)
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and laser scan microscopy, respectively (Fig. 2a, b).
The data were confirmed with 3H-thymidine-labelled
bacteria. Following incubation for 3 h at 37 °C or 4 °C,
cell-associated radioactivity was measured, and was found
to be similar at the two temperatures. Binding could be
inhibited by heparin (on average by 30 %) as reported be-
fore by others [28] (Table 1). To determine uptake of bac-
teria, again 3H-thymidine-labelled bacteria were used.
Following incubation with osteoblasts for 3 h at either
4 °C or 37 °C, the cells were treated with vancomycin
to kill adherent, but not internalised cells; then cell lysates
were prepared and spread onto agar plates. After 24 h,
bacteria colonies were counted as indicator of internalised
bacteria. As seen in Table 1, internalisation occurred at
37 °C, but not at 4 °C (data summarised in Table 1).
In a next set of experiments effects on cytokine release
in response to bacteria was measured. When osteoblasts
were exposed to live bacteria, an increase in mRNA of
IL-6, IL-8 and CCL2 was observed (Fig. 3a), and after
prolonged incubation also release into the surrounding
medium. IL-8 release was delayed compared to release
of CCL2 (Fig. 3b, c). The absolute concentrations of cy-
tokines varied widely when cells of different donors were
compared. In all experiments, however, exposure to bac-
teria increased the concentration of IL-6, IL-8 or CCL2.
On a given bacteria-to-osteoblast ratio, S. epidermidis
apparently induced more cytokines compared to S.
aureus, although due to the wide variation of re-
sponses, a categorical difference cannot be deduced
(Fig. 3d). Of note, initial contact of osteoblasts with
37 C 4 Co o
A
B
green fluorescence
Fig. 2 Binding and uptake of S. aureus to osteoblasts: a Osteoblasts were incubated with FITC-labelled bacteria at either 37 ° C or 4 °C.
Then fluorescence associated with the cells was determined (the very left panel shows the autofluorescence of the cells). b Binding and
uptake of bacteria could be confirmed by laser scan microscopy (bacteria in green; nuclei in blue)
Table 1 Phagocytosis of live bacteria
bacteria associated with cells (% of input) (mean of n = 4) colonies counted after 24 h
37 °C 4 °C 37 °C 4 °C
osteoblasts + S. epidermidis 47 ± 15 51 ± 21 257; 65* 52; 14*
osteoblasts + heparin + S.epidermidis 39 ± 21 34 ± 12 67; 38* 7; 8*
*The values represent each the mean of duplicates; two independent experiments are shown
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bacteria at 4 °C, which results in binding but not in up-
take, was sufficient to induce cytokine synthesis (Fig. 3e).
Effects of extracellular biofilm substance on osteoblasts
To gain information on effects of bacterial biofilms
on osteoblasts, soluble entities of the extracellular
polymeric substance (EPS) of biofilms were prepared.
EPS consists mainly of water, a variety of glycopro-
teins and complex carbohydrates, lipids, and bacterial
DNA. Total EPS when added in high concentration
(10 % (v/v)) was toxic for the osteoblasts, lower con-
centrations of 2 % induced synthesis of IL-8, IL-6,
and CCL2 (Fig. 4a). Precipitating proteins from the
EPS revealed that both, the precipitated protein frac-
tion, as well as the remaining non-precipitable frac-
tion contained activating entities. A reasonable good
candidate for the non-precipitable entity is lipotei-
choic acid (LTA); and indeed, we could demonstrate
an activation of cytokine synthesis and release by LTA
(data summarised in Fig. 4a). We further tested the
bacterial heat shock protein GroEL, which is present
in the protein fraction of EPS. GroEL induced IL-6,
IL-8 and CCL2 release within 6 to 24 h. Again, the
responsiveness varied among donors, and again, re-
lease of IL-8 was somewhat prolonged compared to
CCL2 (Fig. 4a–f ). The effect on IL-8 induction was
also small, but conspicuous when directly comparing
unstimulated cells with cells exposed to GroEL derived
from the same individual (data summarised in Fig. 4c).
Discussion
Implant-associated infections are a feared complica-
tion in the field of orthopaedics, since these infections
are difficult to diagnose and usually require prolonged
treatment [29–31]. The reason for these difficulties is
ascribed to the fact that bacteria attach to an implant
surface, produce and embed themselves in an extra-
cellular polymeric substance and are thus capable of
forming biofilm-colonies that are resistant to anti-
biotic treatment (reviewed in [17–19, 32, 33]). More-
over, it has been proposed that bacteria in biofilms
are protected from the immune system; the latter
even being incapable of recognising biofilms [34–36].
However, given the fact that biofilm-formation is ac-
tually the preferred and thus probably predominant
living-form of bacteria, makes it unlikely that the
immune system does not respond to these infections.
In support of this theory it has been shown that im-
mune cells infiltrate areas of biofilm formation and
attack biofilms [22, 37]. Of note, phagocytic cells
recognize biofilms even without opsonisation; a
process which is required for recognition and phago-
cytosis of free-swimming bacteria [38, 39]. Indeed,
neutrophils were activated by the eluted extracellular
matrix, and more recently, we identified lipoteichoic
acid (LTA) and the bacterial heat shock protein
GroEL as activating entities within the biofilm matrix
[26]. In neutrophils, GroEL leads to an up-regulation
of activation-associated markers on the cell surface
and increased oxygen radical production [26].
Since neutrophils are not necessarily the first cells
to encounter a biofilm infection, we now evaluated
the effects of the extracellular polymeric substance,
LTA, and GroEL on local tissue cells, namely osteo-
blasts. We were able to demonstrate that osteoblasts
responded by an increased production of pro-
inflammatory cytokines which in turn can attract
immuno-competent cells, and might thus initiate or
perpetuate the defence against biofilm infections. That
osteoblasts produce cytokines in response to inflam-
matory stimuli has been reported before by others
[4]; the novel aspect of our study is, that bacteria-
derived entities and by implication bacterial biofilms
activate the inflammatory potential of osteoblasts,
most likely as the first reaction to an infection.
Another interesting aspect of osteoblast-bacteria
interaction is the uptake of bacteria by osteoblasts
and the intracellular survival of bacteria. In extension
of previous studies by others [3, 28, 40] we found
that the contact of bacteria with the osteoblast is suf-
ficient to induce cytokine induction. Moreover, in line
with data by others, this effect could be inhibited by
heparin, which interacts with fibronectin-binding; the
latter being essential for internalization of bacteria
[28, 41]. We also demonstrated that bacteria are cap-
able of intracellular survival in osteoblasts which
might offer a feasible explanation of persisting and re-
curring bone infections. These findings are in line
with our previous findings on enhanced cytokine ex-
pression in the tissue surrounding an infected implant
which might be generated not merely by infiltrating
leukocytes, but also local tissue cells [24, 42, 43].
(See figure on previous page.)
Fig. 3 Cytokine production and release in response to bacteria: a Osteoblasts were cultivated with S. epidermidis in two concentrations and after
6 h, RNA for IL-6, IL-8, and CCL2 was quantified (data with cells of one individual are shown; mean of duplicates). Cytokine release into the supernatant
was determined 24 h and 48 h after exposure to either S. aureus or S. epidermidis (bacteria to cell ratio 100 or 500 bacteria/per cell) (b) or (c) with a ratio
of 1:20;100 or 500 (data with cells of one individual are shown). d shows the summary of experiments with cells of 5 individuals stimulated
with bacteria (1:100) for 24 h. e osteoblasts were cultivated with bacteria (1:100) at either 4 °C or 37 °C for 20 min; after washing culture was
continued for 24 h and cytokines in the supernatant were measured
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Conclusion
In conclusion, we were able to show that aside from the
obvious role of osteoblasts in bone formation, they also
respond to bacterial infections. Osteoblasts are capable
of increased expression and release of pro-inflammatory
cytokines when challenged with free-swimming bacteria.
Furthermore, we demonstrated internalization of bac-
teria and intracellular survival as a method of bacterial
persistence leading to chronic infectious disease.
Osteoblasts not only respond to free-swimming bac-
teria, but also to components of the extracellular poly-
meric substance, among them the bacterial heat shock
protein GroEL, and may therefore be critically involved
in defence mechanisms against biofilm infections.
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Fig. 4 Cytokine production and release in response to bacterial biofilm
EPS or EPS-derived materials: a Osteoblasts were cultivated for 6 h with
either LTA1 (1 μg/mL), GroEL1 or GroEL5 (1 and 5 μg/mL, respectively),
or EPS2 (2 % (v/v)) extracted from S. epidermidis biofilms; then cytokine
production was determined by quantitative RT-PCR (data of 5 indi-
viduals are summarized). b and c show a dose–response curve for
GroEL with cells from one individual (mean of duplicates); RT-PCR
was performed after 6 h in culture, release into the supernatant
after 24 h. d–f show the summary of experiments with cells of 5–7
individuals. Cytokines were measured in the cell-free supernatant
after 24 h stimulation with LTA1 and LTA5 (1 and 5 μg/mL,
respectively) (for CCL2, only LTA1 was measured), GroEL1 and
GroEL5 (1 and 5 μg/mL, respectively) or EPS2 (2 % (v/v))
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